Characterization of the sequence and architectural constraints of the regulatory and core regions of the human interleukin-2 promoter

Molecular Immunology

Volumn 44, Issue 11, 2007, Pages 2813-2819

  Weaver, Jessica R ^a   Good, Kristi ^a   Walters, Ryan D ^a   Kugel, Jennifer F ^a   Goodrich, James A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Enhancer; Interleukin 2; Promoter; Transcription

Indexed keywords

ENHANCEOSOME; INTERLEUKIN 2;

ARTICLE; BINDING SITE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; TATA BOX;

BASE SEQUENCE; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS; TATA BOX; TRANSCRIPTION, GENETIC;

EID: 33947170493     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.01.027     Document Type: Article

References (35)

1. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212 (1990) 563-578
2. Chen C.Y., Del Gatto-Konczak F., Wu Z., and Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280 (1998) 1945-1949
3. Crabtree G.R., and Clipstone N.A. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63 (1994) 1045-1083
4. Deng W., and Roberts S.G. A core promoter element downstream of the TATA box that is recognized by TFIIB. Genes Dev. 19 (2005) 2418-2423
5. Durand D.B., Bush M.R., Morgan J.G., Weiss A., and Crabtree G.R. A 275-basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T-cell antigen receptor. J. Exp. Med. 165 (1987) 395-407
6. Durand D.B., Shaw J.-P., Bush M.R., Replogle R.E., Belagaje R., and Crabtree G.R. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8 (1988) 1715-1724
7. Falvo J.V., Thanos D., and Maniatis T. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83 (1995) 1101-1111
8. Falvo J.V., Uglialoro A.M., Brinkman B.M., Merika M., Parekh B.S., Tsai E.Y., King H.C., Morielli A.D., Peralta E.G., Maniatis T., Thanos D., and Goldfeld A.E. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol. Cell. Biol. 20 (2000) 2239-2247
9. Ferguson H.A., Kugel J.F., and Goodrich J.A. Kinetic and mechanistic analysis of the RNA polymerase II transcription reaction at the human interleukin-2 promoter. J. Mol. Biol. 314 (2001) 993-1006
10. Flanagan W.M., and Crabtree G.R. In vitro transcription faithfully reflecting T-cell activation requirements. J. Biol. Chem. 267 (1992) 399-406
11. Fujita T., Shibuya H., Ohashi T., Yamanishi K., and Taniguchi T. Regulation of human interleukin-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes. Cell 46 (1986) 401-405
12. Giese K., Cox J., and Grosschedl R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69 (1992) 185-195
13. Giese K., and Grosschedl R. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 12 (1993) 4667-4676
14. Giese K., Kingsley C., Kirshner J.R., and Grosschedl R. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9 (1995) 995-1008
15. Goodbourn S. T-cell activation, transcriptional regulation in activated T cells. Curr. Biol. 4 (1994) 930-932
16. Hentsch B., Mouzaki A., Pfeuffer I., Rungger D., and Serfling E. The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity. Nucleic Acids Res. 20 (1992) 2657-2665
17. Himes S.R., Reeves R., Attema J., Nissen M., Li Y., and Shannon M.F. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J. Immunol. 164 (2000) 3157-3168
18. Hoyos B., Ballard D.W., Bohnlein E., Siekevitz M., and Greene W.C. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244 (1989) 457-460
19. Jain J., Loh C., and Rao A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7 (1995) 333-342
20. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., and Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14 (1994) 116-127
21. Juven-Gershon T., Hsu J.Y., and Kadonaga J.T. Perspectives on the RNA polymerase II core promoter. Biochem. Soc. Trans. 34 (2006) 1047-1050
22. Kamps M.P., Corcoran L., LeBowitz J.H., and Baltimore D. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10 (1990) 5464-5472
23. Khoury G., and Gruss P. Enhancer elements. Cell 33 (1983) 313-314
24. Lo K., and Smale S.T. Generality of a functional initiator consensus sequence. Gene 182 (1996) 13-22
25. Maniatis T., Goodbourn S., and Fischer J.A. Regulation of inducible and tissue-specific gene expression. Science 236 (1987) 1237-1245
26. Merika M., and Thanos D. Enhanceosomes. Curr. Opin. Genet. Dev. 11 (2001) 205-208
27. Rooney J.W., Sun Y.L., Glimcher L.H., and Hoey T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15 (1995) 6299-6310
28. Rothenberg E.V., and Ward S.B. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9358-9365
29. Serfling E., Barthelmas R., Pfeuffer I., Schenk B., Zarius S., Swoboda R., Mercurio F., and Karin M. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8 (1989) 465-473
30. Thanos D., and Maniatis T. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 71 (1992) 777-789
31. Thanos D., and Maniatis T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83 (1995) 1091-1100
32. Tjian R., and Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77 (1994) 5-8
33. Ullman K.S., Flanagan W.M., Edwards C.A., and Crabtree G.R. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254 (1991) 558-562
34. Ullman K.S., Northrop J.P., Verweij C.L., and Crabtree G.R. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Ann. Rev. Immunol. 8 (1990) 421-452
35. Yie J., Senger K., and Thanos D. Mechanism by which the IFN-beta enhanceosome activates transcription. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13108-13113